Replies to post #91174 on Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

Obviously, it's not a good look, but their explanation that it's related to the amendment they want to make with the trial design is reasonable. A hold relating to safety would have been very bad news.

This one? Not so much.